Immune Checkpoint Inhibitors Mediated Lymphocytic and Giant Cell Myocarditis: Uncovering Etiological Mechanisms

The advent of immune checkpoint inhibitors (ICIs) has revolutionized the field of oncology, but these are associated with immune related adverse events. One such adverse event, is myocarditis, which has limited the continued immunosuppressive treatment options in patients afflicted by the disease. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Rikhi, Rishi, Karnuta, Jaret, Hussain, Muzna, Collier, Patrick, Funchain, Pauline, Tang, Wai Hong Wilson, Chan, Timothy A., Moudgil, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381278/
https://www.ncbi.nlm.nih.gov/pubmed/34434981
http://dx.doi.org/10.3389/fcvm.2021.721333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381278/
https://www.ncbi.nlm.nih.gov/pubmed/34434981
http://dx.doi.org/10.3389/fcvm.2021.721333

Ejemplares similares